Careers Media center Contacts
KANAMYCIN
KANAMYCIN

kanamycin | J01GB04

Powder for injection

Severe purulent-septic diseases (sepsis, meningitis, peritonitis, septic endocarditis); infectious-inflammatory respiratory disease (pneumonia, pleural empyema, lung abscess); infections of the kidneys and urinary tract; suppurative complications in the postoperative period; infected burns; tuberculosis of the lungs and other organs tuberculous lesions caused by microorganisms resistant to antituberculous drugs I and II series and sensitive to kanamycin.

KIMACEF
KIMACEF

сefuroxime | J01D C02

Powder for injection

Treatment of infections caused by susceptible to cefuroxime by microorganisms or therapy to determine the infectious agent.
Infectious diseases of the respiratory tract: acute and chronic bronchitis, infected bronchiectasis, bacterial pneumonia, lung abscess, postoperative infections of the chest; infectious diseases of the nose and throat: sinusitis, tonsillitis, pharyngitis; infectious diseases of the urinary tract: acute and chronic pyelonephritis, cystitis, asymptomatic bacteriuria; infectious diseases of soft tissues: cellulites, erysipeloid, wound infection; infectious diseases of joints and bones: osteomyelitis, septic arthritis; infections in obstetrics and gynecology: an infectious-inflammatory diseases of the pelvic organs; gonorrhoea, especially in those cases when penicillin is contraindicated; other infectious diseases, including septicemia and meningitis. Prevention of infectious complications after operations on the thorax and abdomen, operations on the pelvic organs, vascular, cardiovascular and orthopedic operations. In most cases, monotherapy drug Kimacef is an effective, but if necessary, the drug can be used in combination with aminoglycoside antibiotics, or metronidazole (oral, rectal suppositories or injectable).In the case of existing or anticipated mixed aerobic and anaerobic infections (e.g., peritonitis, aspiration pneumonia, lung abscess, pelvic and brain) and the high incidence of such infections (e.g., in operations on the colon and gynecological surgery) acceptable is the drug of Kimacef in combination with metronidazole. In the treatment of pneumonia and exacerbation of chronic bronchitis drug Kimacef can be administered prior to oral application of the cefuroxime axetil when needed.

L-LYSINE AESCINAT
L-LYSINE AESCINAT

lysine | С05С Х

Solution for injection

As part of complex treatment of post-traumatic, intra- and postoperative oedemas of any localization, i.e. severe cerebral and spinal oedemas, including those with intracranial hemorrhages, increased intracranial pressure and dropsical swelling; liquor-venous disturbances in patients with chronic ischemia of the brain and vegetative-vascular dystonia; soft tissue oedemas involving musculoskeletal system accompanied with local blood circulation disorders and pain syndrome; oedematous and pain syndromes in the spine, body, and extremities; severe venous circulation disorders of the low extremities in patients with acute thrombophlebitis accompanied with swelling inflammation syndrome.

LAEVOMYCETIN
LAEVOMYCETIN

chloramphenicol | J01BA01

Tablets

Infectious inflammatory diseases due to laevomycetin-susceptible microorganisms: typhoid fever, paratyphoid fever, shigellosis, salmonellosis, brucellosis, tularemia, ricketsiosis (including spotted fever, trachoma).

LAEVOMYCETIN
LAEVOMYCETIN

сhloramphenicol | J01В А01

Powder for injection

Laevomycetin is indicated for typhoid fever, paratyphoid fever, generalized forms of salmonellosis, dysentery, brucellosis, tularemia, meningitis, spotted fever and other ricketsioses, trachoma. Infectious processes due to laevomycetin-susceptible pathogens when other chemotherapeutic preparations are ineffective or their administration is not feasible.

LANCEROL
LANCEROL

lansoprazole | А02ВС03

Capsules

Benign peptic ulcer and duodenal ulcer, including those associated with the use of NSAIDs; gastroesophageal reflux disease; syndrome Zollinger-Ellison; for eradication of Helicobacter pylori (in combination with antibiotics).

LIDOCAINE HYDROCHLORIDE
LIDOCAINE HYDROCHLORIDE

lidocaine | N01ВВ02

Solution for injection

As a local anesthetic agent, lidocaine hydrochloride solution is used for: infiltration anesthesia in surgical interventions; regional anesthesia in dental procedures and surgical procedures on the extremities; plexus nerve block; topical anesthesia of mucous membranes in urology, ophthalmology, dentistry.

LINCOMYCIN
LINCOMYCIN

lincomycin | J01F F02

Capsules

Infections due to microorganisms susceptible to the drug: infections of bones and joints (osteomyelitis, septic arthritis); infections of ENT organs and respiratory tract, otitis, sinusitis, acute bronchitis, pneumonia; purulent skin and soft tissue infections (furunculosis, abscess, infected wound, panaritium, mastitis), erysipelatous inflammation.


The presented package image matches the product design registered with the Ukrainian regulatory authorities.

If you have noticed any differences, please call us at +380 44 490 75 22

PHARMACOVIGILANCE

If you have information about any adverse effects or other drug-related problems, please fill in the form